254 related articles for article (PubMed ID: 22906862)
1. Prevalence and control of dyslipidaemia among diabetic patients with microalbuminuria in a Chinese hospital.
Wang SH; Wang L; Zhou Y; Guo YJ; Yuan Y; Li FF; Huang Y; Xia WQ
Diab Vasc Dis Res; 2013 Mar; 10(2):169-78. PubMed ID: 22906862
[TBL] [Abstract][Full Text] [Related]
2. Dyslipidaemia among diabetic patients with ischemic stroke in a Chinese hospital.
Wang SH; Sun ZL; Ruan XZ; Guo YJ; Wang Y; Jin H; Yuan Y; Wei Q
Chin Med J (Engl); 2009 Nov; 122(21):2567-72. PubMed ID: 19951571
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS).
Zhao S; Wang Y; Mu Y; Yu B; Ye P; Yan X; Li Z; Wei Y; Ambegaonakr BM; Hu D;
Atherosclerosis; 2014 Aug; 235(2):463-9. PubMed ID: 24950001
[TBL] [Abstract][Full Text] [Related]
4. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
Bruckert E; Baccara-Dinet M; Eschwege E
Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
[TBL] [Abstract][Full Text] [Related]
6. Lipid-lowering therapy and lipid goal attainment in patients with metabolic syndrome in China: subgroup analysis of the Dyslipidemia International Study-China (DYSIS-China).
Wang F; Ye P; Hu D; Min Y; Zhao S; Wang Y; Mu Y; Yan X; Li Z; Wei Y; Li J;
Atherosclerosis; 2014 Nov; 237(1):99-105. PubMed ID: 25238215
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and control of dyslipidemia among persons with diabetes in the United States.
Jacobs MJ; Kleisli T; Pio JR; Malik S; L'Italien GJ; Chen RS; Wong ND
Diabetes Res Clin Pract; 2005 Dec; 70(3):263-9. PubMed ID: 15890427
[TBL] [Abstract][Full Text] [Related]
8. [Lower levels of HDL2 cholesterol are associated with microalbuminuria in patients with type 1 diabetes].
Bulum T; Duvnjak L; Prkacin I
Acta Med Croatica; 2011; 65(3):243-50. PubMed ID: 22359892
[TBL] [Abstract][Full Text] [Related]
9. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
10. The Management of Dyslipidaemia in Patients with Type 2 Diabetes Mellitus Receiving Lipid-Lowering Drugs: A Sub-Analysis of the CEPHEUS Findings.
Shehab A; Al-Rasadi K; Arafah M; Al-Hinai AT; Al Mahmeed W; Bhagavathula AS; Al Tamimi O; Al Herz S; Al Anazi F; Al Nemer K; Metwally O; Alkhadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al Jassim O; Al Hallaq O; Baslaib FOAS; Alawadhi M; Amin H; Al-Hashmi K; Oulhaj A
Curr Vasc Pharmacol; 2018; 16(4):368-375. PubMed ID: 28677510
[TBL] [Abstract][Full Text] [Related]
11. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
[TBL] [Abstract][Full Text] [Related]
12. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: the di@bet.es study.
Martinez-Hervas S; Carmena R; Ascaso JF; Real JT; Masana L; Catalá M; Vendrell J; Vázquez JA; Valdés S; Urrutia I; Soriguer F; Serrano-Rios M; Rojo-Martínez G; Pascual-Manich G; Ortega E; Mora-Peces I; Menéndez E; Martínez-Larrad MT; López-Alba A; Gomis R; Goday A; Girbés J; Gaztambide S; Franch J; Delgado E; Castell C; Castaño L; Casamitjana R; Calle-Pascual A; Bordiú E
Clin Investig Arterioscler; 2014; 26(3):107-14. PubMed ID: 24461346
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease].
Pérez A; González Blanco C; Hernández-Presa MÁ; Chaves J
Endocrinol Nutr; 2011; 58(6):283-90. PubMed ID: 21641286
[TBL] [Abstract][Full Text] [Related]
15. Comparison of therapeutic lipid target achievements among high-risk patients in Oman.
Al-Waili K; Al-Zakwani I; Al-Dughaishi T; Baneerje Y; Al-Sabti H; Al-Hashmi K; Farhan H; Habsi KA; Al-Hinai AT; Al-Rasadi K
Angiology; 2014 May; 65(5):430-5. PubMed ID: 23564019
[TBL] [Abstract][Full Text] [Related]
16. Effects of albuminuria and renal dysfunction on development of dyslipidaemia in type 2 diabetes--the Hong Kong Diabetes Registry.
Yang X; So WY; Ma R; Ko G; Kong A; Lam C; Ho CS; Cockram C; Chow CC; Tong P; Chan J
Nephrol Dial Transplant; 2008 Sep; 23(9):2834-40. PubMed ID: 18372388
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs.
Laforest L; Souchet T; Moulin P; Ritleng C; Desamericq G; Le Jeunne P; Schwalm MS; Van Ganse E
Arch Cardiovasc Dis; 2009 Jan; 102(1):43-50. PubMed ID: 19233108
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of dyslipidaemia in patients with renal cell carcinoma: a case-control study in China.
Zhang GM; Zhu Y; Luo L; Zhang HL; Gu CY; Sun LJ; Ye DW
BJU Int; 2014 May; 113(5b):E75-81. PubMed ID: 24274674
[TBL] [Abstract][Full Text] [Related]
19. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
